Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer. Homo sapiens
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA243023
下载链接
链接失效反馈官方服务：
资源简介：
We analyzed transcriptional changes in 4 prostate cancer cell lines following treatment with the BET inhibitor I-BET762 using Affymetrix Human Genome U133 Plus 2.0 Arrays. Overall design: Four prostate cancer cell lines (NCI-H660, VCaP, LNCaP, PC-3) were treated with DMSO (control) or I-BET762 at 0.5uM or 10uM concentrations for 24 hours. Two biological replicates are included for each treatment group.
创建时间：
2014-03-31
